Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.800
-0.010 (-0.55%)
At close: Dec 20, 2024, 4:00 PM
1.839
+0.039 (2.18%)
After-hours: Dec 20, 2024, 7:02 PM EST
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $162.99 million as of December 20, 2024. Its market cap has decreased by -69.02% in one year.
Market Cap
162.99M
Enterprise Value
-91.38M
1-Year Change
-69.02%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $162.99M, a decrease of -81.65%. That is a compound annual growth rate of -39.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 162.99M | -67.83% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 168.93M |
| Nektar Therapeutics | 166.57M |
| scPharmaceuticals | 165.88M |
| TScan Therapeutics | 165.56M |
| ModivCare | 164.83M |
| Fennec Pharmaceuticals | 163.19M |
| Sagimet Biosciences | 162.91M |
| Nutex Health | 162.89M |